CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
Country • Select Country
    Entity • The products and services listed on this website are not available to US residents.
    English العَرَبِيَّة Deutsch ελληνικά Español Français Italiano Magyar Nederlands Polski Română Русский 简体中文 繁體中文

    Trade Recordati SPA - RECm CFD

    45.23
    0.42%
    0.16
    Low: 44.45
    High: 45.6
    Market Trading Hours* (UTC) Opens on Monday at 07:00

    Mon - Fri: 07:00 - 15:30

    • Summary
    • Historical Data
    • Events
    • Income Statement
    • Balance Sheet
    • Cash Flow
    • Ownership
    Trading Conditions
    Spread 0.16
    Long position overnight fee

    Long position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.021388 %
    Charges from full value of position ($-4.06)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.021388%
    Short position overnight fee

    Short position overnight fee

    Margin. Your investment $1,000.00
    Overnight fee -0.000834 %
    Charges from full value of position ($-0.16)
    Trade size with leverage ~ $20,000.00
    Money from leverage ~ $19,000.00
    Go to platform
    		-0.000834%
    Overnight fee time 21:00 (UTC)
    Min traded quantity 1
    Currency EUR
    Margin 5%
    Stock exchange Italy
    Commission on trade 0%

    *Information provided by Capital.com

    Recordati Industria Chimica e Farmaceutica SpA ESG Risk Ratings

    High Medium Low Negligible

    ‘A’ score indicates excellent relative ESG performance and high degree of transparency in reporting material ESG data publicly

    More ESG coverage

    Key Stats
    Prev. Close* 45.04
    Open* 44.45
    1-Year Change* 14.41%
    Day's Range* 44.45 - 45.6
    52 wk Range 34.52-47.34
    Average Volume (10 days) 285.08K
    Average Volume (3 months) 5.07M
    Market Cap 9.41B
    P/E Ratio 23.94
    Shares Outstanding 205.54M
    Revenue 2.01B
    EPS 1.88
    Dividend (Yield %) 2.55499
    Beta 0.25
    Next Earnings Date Nov 7, 2023

    All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

    • Last Week
    • Last Month
    • Last Year
    • Last two Years
    • Max
    • Daily
    • Weekly
    • Monthly
    Date Close Change Change (%) Open High Low
    Sep 22, 2023 45.23 0.73 1.64% 44.50 45.66 44.21
    Sep 21, 2023 45.04 -2.15 -4.56% 47.19 47.30 44.95
    Sep 20, 2023 47.45 0.48 1.02% 46.97 47.78 46.86
    Sep 19, 2023 46.87 0.04 0.09% 46.83 47.23 46.29
    Sep 18, 2023 46.84 0.25 0.54% 46.59 47.07 46.41
    Sep 15, 2023 46.43 -0.15 -0.32% 46.58 47.60 46.42
    Sep 14, 2023 46.26 0.66 1.45% 45.60 46.31 45.06
    Sep 13, 2023 45.64 0.33 0.73% 45.31 45.71 45.13
    Sep 12, 2023 45.33 0.27 0.60% 45.06 45.62 44.92
    Sep 11, 2023 45.11 -0.50 -1.10% 45.61 45.70 44.40
    Sep 8, 2023 45.37 0.37 0.82% 45.00 45.45 44.71
    Sep 7, 2023 45.00 0.84 1.90% 44.16 45.07 43.72
    Sep 6, 2023 44.29 -0.65 -1.45% 44.94 45.23 44.18
    Sep 5, 2023 45.06 -0.20 -0.44% 45.26 45.76 45.06
    Sep 4, 2023 45.33 -0.40 -0.87% 45.73 45.90 45.33
    Sep 1, 2023 45.59 -0.37 -0.81% 45.96 46.11 44.64
    Aug 31, 2023 46.46 0.04 0.09% 46.42 46.82 46.41
    Aug 30, 2023 46.38 -0.49 -1.05% 46.87 46.91 46.09
    Aug 29, 2023 46.70 0.66 1.43% 46.04 46.85 46.04
    Aug 28, 2023 46.13 0.18 0.39% 45.95 46.54 45.92

    Recordati SPA Events

    Time (UTC) Country Event
    Tuesday, November 7, 2023

    Time (UTC)

    10:59

    Country

    IT

    Event

    Q3 2023 Recordati Industria Chimica e Farmaceutica SpA Earnings Release
    Q3 2023 Recordati Industria Chimica e Farmaceutica SpA Earnings Release

    Forecast

    -

    Previous

    -
    Monday, February 19, 2024

    Time (UTC)

    10:59

    Country

    IT

    Event

    Q4 2023 Recordati Industria Chimica e Farmaceutica SpA Earnings Release
    Q4 2023 Recordati Industria Chimica e Farmaceutica SpA Earnings Release

    Forecast

    -

    Previous

    -
    View all events
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total revenue 1853.31 1580.07 1448.87 1481.85 1352.23
    Revenue 1853.31 1580.07 1448.87 1481.85 1352.23
    Cost of Revenue, Total 566.737 427.727 406.831 436.901 395.569
    Gross Profit 1286.57 1152.35 1042.04 1044.95 956.666
    Total Operating Expense 1411.47 1089.88 979.851 1016.58 910.016
    Selling/General/Admin. Expenses, Total 572.158 480.889 421.857 445.586 401.219
    Research & Development 220.102 166.138 146.236 77.081 67.093
    Unusual Expense (Income) 52.975 14.478 4.927 0.264 3.535
    Operating Income 441.832 490.19 469.016 465.266 442.219
    Interest Income (Expense), Net Non-Operating -40.252 -26.718 -13.203 -20.616 -17.977
    Other, Net -0.145 -0.123 -0.157 -0.506 -6.307
    Net Income Before Taxes 401.435 463.349 455.656 444.144 417.935
    Net Income After Taxes 312.336 385.966 355.027 368.866 312.422
    Minority Interest 0 0 -0.043 -0.041 -0.046
    Net Income Before Extra. Items 312.336 385.966 354.984 368.825 312.376
    Net Income 312.336 385.966 354.984 368.825 312.376
    Income Available to Common Excl. Extra. Items 312.336 385.966 354.984 368.825 312.376
    Income Available to Common Incl. Extra. Items 312.336 385.966 354.984 368.825 312.376
    Dilution Adjustment
    Diluted Net Income 312.336 385.966 354.984 368.825 312.376
    Diluted Weighted Average Shares 205.582 209.082 209.06 209.084 209.087
    Diluted EPS Excluding Extraordinary Items 1.51928 1.846 1.698 1.764 1.494
    Dividends per Share - Common Stock Primary Issue 1.15 1.1 1.05 1 0.92
    Diluted Normalized EPS 1.57912 1.89642 1.7131 1.76505 1.50664
    Depreciation / Amortization 52.6 42.6
    Other Operating Expenses, Total -0.497 0.652 0 4.15
    Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
    Total revenue 492.909 551.363 475.765 485.052 473.109
    Revenue 492.909 551.363 475.765 485.052 473.109
    Cost of Revenue, Total 148.3 163.654 143.933 154.924 152.402
    Gross Profit 344.609 387.709 331.832 330.128 320.707
    Total Operating Expense 351.991 377.95 384.224 362.353 376.788
    Selling/General/Admin. Expenses, Total 145.206 150.429 160.39 144.952 145.083
    Research & Development 58.585 60.458 64.402 56.367 55.664
    Unusual Expense (Income) 1.095 1.937 12.992 6.715 23.978
    Other Operating Expenses, Total -1.195 1.472 2.507 -0.605 -0.339
    Operating Income 140.918 173.413 91.541 122.699 96.321
    Interest Income (Expense), Net Non-Operating -11.898 -13.38 0.239 -7.103 -26.462
    Other, Net -0.091 -0.092 -0.063 -0.028 -0.027
    Net Income Before Taxes 128.929 159.941 91.717 115.568 69.832
    Net Income After Taxes 103.617 123.954 70.878 90.053 54.685
    Minority Interest 0 0 0 0 0
    Net Income Before Extra. Items 103.617 123.954 70.878 90.053 54.685
    Net Income 103.617 123.954 70.878 90.053 54.685
    Income Available to Common Excl. Extra. Items 103.617 123.954 70.878 90.053 54.685
    Income Available to Common Incl. Extra. Items 103.617 123.954 70.878 90.053 54.685
    Diluted Net Income 103.617 123.954 70.878 90.053 54.685
    Diluted Weighted Average Shares 205.421 209.029 205.417 205.602 208.895
    Diluted EPS Excluding Extraordinary Items 0.50441 0.593 0.34504 0.438 0.26178
    Dividends per Share - Common Stock Primary Issue 0 0 0.6 0 0.55
    Diluted Normalized EPS 0.55119 0.6427 0.36713 0.4423 0.29466
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Total Current Assets 1173.62 850.101 772.951 809.35 699.931
    Cash and Short Term Investments 284.734 244.578 188.23 187.923 198.036
    Cash 162.636 230.924 175.227 141.384 172.421
    Cash & Equivalents 122.098 13.654 13.003 46.539 25.615
    Total Receivables, Net 424.062 350.335 313.859 374.328 281.276
    Accounts Receivable - Trade, Net 361.898 307.778 268.897 296.961 245.742
    Total Inventory 424.08 228.732 251.252 226.885 206.084
    Prepaid Expenses 17.138 15.307 12.574 10.265 8.121
    Other Current Assets, Total 23.603 11.149 7.036 9.949 6.414
    Total Assets 3998.82 2816.2 2711.65 2808.93 2161.26
    Property/Plant/Equipment, Total - Net 159.184 131.12 133.25 133.342 103.582
    Property/Plant/Equipment, Total - Gross 521.17 462.825 453.036 437.716 387.858
    Accumulated Depreciation, Total -361.986 -331.705 -319.786 -304.374 -284.276
    Goodwill, Net 780.057 553.209 562.116 577.973 577.786
    Intangibles, Net 1758.17 1138.79 1115.81 1161.76 672.106
    Long Term Investments 28.871 34.124 45.581 38.566 20.773
    Other Long Term Assets, Total 98.921 108.859 81.945 87.939 87.087
    Total Current Liabilities 923.743 626.416 578.464 586.754 490.742
    Accounts Payable 224.703 177.925 132.096 175.481 165.02
    Accrued Expenses 82.96 56.191 39.649 45.267 42.289
    Notes Payable/Short Term Debt 83.425 8.657 12.567 13.392 16.905
    Current Port. of LT Debt/Capital Leases 291.546 223.061 270.254 149.817 130.583
    Other Current Liabilities, Total 241.109 160.582 123.898 202.797 135.945
    Total Liabilities 2452.57 1434.57 1435.67 1610.35 1197.87
    Total Long Term Debt 1341.55 760.473 778.238 937.344 640.647
    Long Term Debt 1319.98 745.382 760.587 937.344 640.647
    Deferred Income Tax 167.865 26.675 41.219 43.172 43.486
    Minority Interest 0 0 0.277 0.234 0.193
    Other Liabilities, Total 19.418 21.01 37.473 42.849 22.804
    Total Equity 1546.25 1381.62 1275.98 1198.58 963.393
    Common Stock 26.141 26.141 26.141 26.141 26.141
    Additional Paid-In Capital 83.719 83.719 83.719 83.719 83.719
    Retained Earnings (Accumulated Deficit) 1785.72 1612.81 1473.6 1334.42 1161.69
    Treasury Stock - Common -149.559 -126.981 -87.516 -93.48 -145.608
    Other Equity, Total -199.769 -214.06 -219.962 -152.223 -162.545
    Total Liabilities & Shareholders’ Equity 3998.82 2816.2 2711.65 2808.93 2161.26
    Total Common Shares Outstanding 205.441 205.911 206.296 204.959 204.379
    Capital Lease Obligations 21.571 15.091 17.651
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Total Current Assets 1191.21 1173.62 1242.55 1263.25 961.621
    Cash and Short Term Investments 231.294 284.734 346.609 373.762 261.43
    Cash & Equivalents 231.294 284.734 346.609 373.762 261.43
    Total Receivables, Net 488.17 425.813 443.062 440.645 407.68
    Accounts Receivable - Trade, Net 439.594 361.898 393.437 386.711 367.012
    Total Inventory 427.664 424.08 403.981 409.794 256.489
    Other Current Assets, Total 44.08 23.603 48.9 39.046 36.022
    Total Assets 3982.07 3998.82 3977.85 3984.1 3642.95
    Property/Plant/Equipment, Total - Net 162.311 159.184 147.226 143.839 129.207
    Property/Plant/Equipment, Total - Gross 528.919 521.17 504.681 495.512 464.469
    Accumulated Depreciation, Total -366.608 -361.986 -357.455 -351.673 -335.262
    Goodwill, Net 784.537 780.057 707.709 709.042 1125.12
    Intangibles, Net 1725.66 1758.17 1714.51 1711.72 1292.75
    Long Term Investments 24.48 28.871 26.972 19.57 23.34
    Other Long Term Assets, Total 93.88 98.921 138.884 136.683 110.922
    Total Current Liabilities 880.962 923.743 778.04 851.202 725.019
    Accounts Payable 246.983 224.703 219.638 222.533 194.998
    Notes Payable/Short Term Debt 23.232 83.425 5.656 74.279 15.022
    Current Port. of LT Debt/Capital Leases 293.631 291.546 290.496 303.406 252.279
    Other Current Liabilities, Total 317.116 324.069 262.25 250.984 262.72
    Total Liabilities 2327.6 2452.57 2367.38 2490.21 2193.52
    Total Long Term Debt 1263.98 1341.55 1404.18 1450.22 1403.58
    Long Term Debt 1241.75 1319.98 1389.79 1435 1389.77
    Deferred Income Tax 163.737 167.865 163.776 167.462 26.909
    Minority Interest 0 0 0 0 0
    Other Liabilities, Total 18.924 19.418 21.39 21.33 38.015
    Total Equity 1654.47 1546.25 1610.47 1493.89 1449.43
    Common Stock 26.141 26.141 26.141 26.141 26.141
    Additional Paid-In Capital 83.719 83.719 83.719 83.719 83.719
    Retained Earnings (Accumulated Deficit) 1920.3 1785.72 1761.87 1663.8 1699.78
    Treasury Stock - Common -152.695 -149.559 -149.782 -141.16 -144.381
    Other Equity, Total -222.995 -199.769 -111.476 -138.613 -215.826
    Total Liabilities & Shareholders’ Equity 3982.07 3998.82 3977.85 3984.1 3642.95
    Total Common Shares Outstanding 205.358 205.441 205.459 205.665 205.587
    Prepaid Expenses 15.387
    Capital Lease Obligations 22.233 21.571 14.387 15.219 13.81
    • Annual
    • Quarterly
    2022 2021 2020 2019 2018
    Net income/Starting Line 312.336 385.966 355.027 368.866 312.422
    Cash From Operating Activities 461.691 492.129 403.575 318.7 357.838
    Cash From Operating Activities 27.289 25.294 25.355 25.17 13.901
    Amortization 98.467 72.291 68.317 53.078 42.959
    Deferred Taxes -6.637
    Non-Cash Items 209.716 113.194 124.979 102.747 4.697
    Changes in Working Capital -186.117 -104.616 -170.103 -231.161 -9.504
    Cash From Investing Activities -767.124 -87.499 -131.555 -441.209 -231.778
    Capital Expenditures -96.339 -87.36 -131.678 -443.288 -19.362
    Other Investing Cash Flow Items, Total -670.785 -0.139 0.123 2.079 -212.416
    Cash From Financing Activities 341.277 -355.943 -264.288 109.526 -224.688
    Financing Cash Flow Items 1.74 -2.19 0.439
    Total Cash Dividends Paid -230.602 -216.742 -212.718 -190.916 -178.887
    Issuance (Retirement) of Stock, Net -38.619 -59.308 -12.17 26.187 -149.552
    Issuance (Retirement) of Debt, Net 610.498 -79.893 -41.14 276.445 103.312
    Net Change in Cash 40.156 56.348 0.307 -10.113 -104.369
    Foreign Exchange Effects 4.312 7.661 -7.425 2.87 -5.741
    Cash Taxes Paid 89.764 91.646 65.272 140.14
    Cash Interest Paid 20.093 18.279 18.699 17.597
    Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
    Net income/Starting Line 123.954 312.336 241.458 151.405 96.72
    Cash From Operating Activities 107.923 461.691 361.692 226.113 113.431
    Cash From Operating Activities 7.004 27.289 19.675 12.895 6.016
    Amortization 27.188 98.467 70.563 44.289 18.635
    Non-Cash Items 66.727 209.716 145.296 97.032 35.714
    Cash Taxes Paid 12.33 89.764 55.992 42.515 10.653
    Cash Interest Paid 17.818 20.093 14.385 8.569 2.344
    Changes in Working Capital -116.95 -186.117 -115.3 -79.508 -43.654
    Cash From Investing Activities -14.006 -767.124 -736.385 -715.11 -722.27
    Capital Expenditures -17.557 -96.339 -83.684 -62.222 -15.599
    Other Investing Cash Flow Items, Total 3.551 -670.785 -652.701 -652.888 -706.671
    Cash From Financing Activities -144.562 341.277 452.436 601.573 571.438
    Total Cash Dividends Paid -6.139 -230.602 -120.017 -119.544 -6.219
    Issuance (Retirement) of Stock, Net -4.075 -38.619 -29.989 -16.634 -18.383
    Issuance (Retirement) of Debt, Net -134.348 610.498 602.442 737.751 596.04
    Foreign Exchange Effects -2.795 4.312 24.288 16.608 1.018
    Net Change in Cash -53.44 40.156 102.031 129.184 -36.383
    Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
    Fimei Finanziaria Industriale Mobiliare Ed Immobiliare SpA Holding Company 51.82 108368656 0 2022-12-31 LOW
    Mawer Investment Management Ltd. Investment Advisor 4.997 10449984 -43916 2022-12-07 LOW
    Fidelity Management & Research Company LLC Investment Advisor 3.402 7114438 0 2022-12-31 LOW
    FMR Investment Management (U.K.) Limited Investment Advisor 1.7394 3637578 -12900 2023-06-30 LOW
    The Vanguard Group, Inc. Investment Advisor/Hedge Fund 1.4165 2962262 25699 2023-07-31 LOW
    BlackRock Institutional Trust Company, N.A. Investment Advisor 1.2673 2650202 14183 2023-07-31 LOW
    Norges Bank Investment Management (NBIM) Sovereign Wealth Fund 0.968 2024252 293858 2022-12-31 LOW
    La Financière de l'Echiquier Investment Advisor 0.6879 1438565 -63157 2023-05-31 MED
    Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5654 1182440 718 2023-07-31 LOW
    BlackRock Advisors (UK) Limited Investment Advisor/Hedge Fund 0.4835 1011020 22229 2023-07-31 LOW
    Manulife Investment Management (North America) Limited Investment Advisor 0.4779 999364 1609 2023-06-30 LOW
    Amundi Asset Management, SAS Investment Advisor/Hedge Fund 0.4384 916749 -1663 2023-07-31 LOW
    INVESCO Asset Management Limited Investment Advisor/Hedge Fund 0.4198 877833 12866 2023-06-30 LOW
    Invesco Advisers, Inc. Investment Advisor 0.3717 777303 69272 2023-06-30 LOW
    California Public Employees' Retirement System Pension Fund 0.3634 759886 -15901 2022-06-30 LOW
    Schroder Investment Management Ltd. (SIM) Investment Advisor/Hedge Fund 0.3562 744985 0 2023-06-30 LOW
    Walter Scott & Partners Ltd. Investment Advisor/Hedge Fund 0.3371 705012 -1664 2023-06-30 LOW
    TD Asset Management Inc. Investment Advisor 0.3182 665492 1359 2023-07-31 LOW
    Epoch Investment Partners, Inc. Investment Advisor 0.3134 655311 898 2023-07-31 LOW
    Anima SGR S.p.A. Investment Advisor 0.2878 601954 65096 2023-06-30 LOW

    Trading calculator

    Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

    Trade commission
    0
    • 1:1
    Leverage
    1:1
    • 20
    • 100
    • 500
    • 1000
    • 10000
    Investment
    Trade size (Leverage x Investement):
    Open

    Close

    Short Long
    Past performance is not a reliable indicator of future results For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)
    Profit/Loss

    For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

    Recordati Company profile

    About Recordati Industria Chimica e Farma SpA

    Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The Company is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. It operates through Italchimici SpA, Pro Farma AG and North American marketing rights to Cystadane. The Company owns and operates through Natural Point srl also in the food supplement sector.

    Financial summary

    BRIEF: For the fiscal year ended 31 December 2021, Recordati Industria Chimica e Farma SpA revenues increased 9% to EUR1.58B. Net income increased 9% to EUR386M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Dividend per share increased from EUR1.05 to EUR1.10. Basic Earnings per Share excluding Extraordinary Items increased from EUR1.73 to EUR1.87.

    Industry: Pharmaceuticals (NEC)

    Via M. Civitali, 1
    MILANO
    MILANO 20148
    IT

    Income Statement

    • Annual
    • Quarterly

    News

    EUR/USD tests key support

    EUR/USD is currently testing a key support level after the Federal Reserve indicated a potential extension of higher interest rates.

    14:32, 21 September 2023
    Bank of England building

    BoE leaves rates unchanged, GBP drops further as investors look for more clarity

    The Bank of England has left rates unchanged at 5.25% with a 5-4 vote split after CPI dropped more than expected in August

    11:45, 21 September 2023
    British banknotes and coins photographed directly above. The coins are in a stack, placed on top of the banknotes.

    GBP softer after CPI surprise, JPY focused on any further hints from Ueda

    GBP drops after a softer CPI reading scares investors about the BoE intentions. JPY on the lookout for further policy tweaks from Governor Ueda.

    12:42, 20 September 2023

    How to Trade The Break & Retest

    In this week's instalment, we delve into the Break & Retest pattern—a strategic approach to navigating breakout trades. If you've wrestled with the frustration of false breakouts, incorporating this pattern into your trading toolkit may help you overcome this challenge and put you on the path to becoming a more confident and consistent trader.

    11:59, 20 September 2023

    Cable coils near lows ahead of Fed and BoE rate decisions

    It’s a big week for Cable (GBP/USD) as both the Federal Reserve and the Bank of England are set to make crucial rate decisions.

    14:16, 19 September 2023

    FTSE 100 Technical Outlook - 18 September 2023

    In prior technical outlooks, we highlighted the importance of staying alert in sleepy markets, and last Thursday’s developments on the FTSE 100 serve as a prime illustration of this principle.

    06:55, 19 September 2023
    View of the City of London’s illuminated financial district skyline at dusk

    Market Analysis: FTSE 100 boosted by ECB rate hike end and iron ore rally

    The FTSE 100 rose over 2% on Thursday as the ECB announced no more rate hikes for now.

    13:46, 15 September 2023

    People also watch

    ETH/USD

    1,596.87 Price
    +0.150% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 5.40

    BTC/USD

    26,632.55 Price
    +0.180% 1D Chg, %
    Long position overnight fee -0.0616%
    Short position overnight fee 0.0137%
    Overnight fee time 21:00 (UTC)
    Spread 85.00

    XRP/USD

    0.52 Price
    -0.620% 1D Chg, %
    Long position overnight fee -0.0753%
    Short position overnight fee 0.0069%
    Overnight fee time 21:00 (UTC)
    Spread 0.01192

    Oil - Crude

    90.14 Price
    +0.770% 1D Chg, %
    Long position overnight fee 0.0415%
    Short position overnight fee -0.0634%
    Overnight fee time 21:00 (UTC)
    Spread 0.030

    Still looking for a broker you can trust?

    Join the 555.000+ traders worldwide that chose to trade with Capital.com

    1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading